Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Onur Alkan
Observed names:
O. Alkan,
ONUR ALKAN,
Onur ALKAN
Institutions:
Medeniyet Üniversitesi Göztepe Eğitim ve Araştırma Hastanesi,
Istanbul Medeniyet University
Observed institutions:
Medeniyet Üniversitesi Göztepe Eğitim ve Araştırma Hastanesi,
Istanbul Medeniyet University,
Istanbul University
ORCID:
0000-0002-8558-1654
Observed ORCID:
0000-0002-8558-1654
OpenAlex ID:
A5062766331
Inflammatory and Nutritional Markers Predicting Pathological Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer: A Multicenter Real-World Study
2025
·
Zeliha Birsin
, İsmail Nazlı
, et al.
·
Journal of Clinical Medicine
·
10
PDF
Myelomatous Pleural Effusion: A Rare Involvement in Myeloma
2020
·
Onur Alkan
, Tarik Onur Tiryaki
, et al.
·
Journal of Medical Cases
·
6
PDF
Management of hepatotoxicity associated with CDK4/6 inhibitors and rechallenge strategies in metastatic hormone-positive, HER2-negative breast cancer
2025
·
Nurullah İlhan
, Süleyman Baş
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
5
PDF
Criteria for Hyperinflammation Developing in COVID ‐19: Analysis of 2 Cohorts From Different Periods of the Pandemic
2022
·
Shirkhan Amikishiyev
, M. Guven Gunver
, et al.
·
Arthritis & Rheumatology
·
3
Is Body Mass Index a Prognostic Factor in Metastatic HER2-Positive Breast Cancer? A Real-World Multicenter Study
2025
·
Zeliha Birsin
, Hülya Odabaşı Bükün
, et al.
·
Medicina
·
2
PDF
Prolonged multimodal disease control with trifluridine/tipiracil plus bevacizumab in KRAS-mutant metastatic rectal cancer: a case report
2026
·
Onur Alkan
, Ahmet Başgöze
, et al.
·
Anti-Cancer Drugs
·
1
Pharmacovigilance signals of androgen receptor pathway inhibitors in non-geriatric men with prostate cancer: A FAERS disproportionality analysis.
2026
·
Onur Alkan
, Ismail Nazlı
, et al.
·
Journal of Clinical Oncology
·
1
PDF
High Levels of Circulating IL-6 and IL-8 Signature can Predict COVID-19 Severity
2021
·
Didem Ozgür
, Murat Karamese
, et al.
·
Jundishapur Journal of Microbiology
·
1
PDF
Onkolojide Güncel Tedavi Yaklaşımları III
2026
·
Abdullah Sakin
, Esra Özer
, et al.
·
Akademisyen Kitabevi eBooks
Hormon Reseptörü Pozitif/Her2 Negatif Metastatik Meme Kanserinde Moleküler Mekanizma ve Güncel Tedavi Yaklaşımları
2026
·
Onur Alkan
·
Akademisyen Kitabevi eBooks
Comment on the article [Expression of miR-101-3p and its target ADAM15 gene in colorectal cancer patients]
2026
·
Onur Alkan
, İsmail Nazlı
, et al.
·
Çukurova medical journal (Online)/Çukurova medical journal
PDF
Pharmacovigilance of Androgen Receptor Pathway Inhibitors in Prostate Cancer: The Impact of Docetaxel Co-Reporting
2026
·
Onur Alkan
, İsmail Nazlı
, et al.
·
Cancers
Landmark-based stratification by at least 90% prostate-specific antigen decline and prostate-specific antigen nadir in androgen receptor pathway inhibitor–treated metastatic hormone-sensitive prostate cancer
2026
·
Vali Aliyev
, İsmail Nazlı
, et al.
·
Prostate International
PDF
Prognostic Value of the Halp Score in Metastatic Urothelial Carcinoma Treated With First-line Platinum-based Chemotherapy
2026
·
Fatih Atalah
, Akgün Karakök
, et al.
·
Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi
Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group
2026
·
Mustafa Seyyar
, Pervin Can Şancı
, et al.
·
BMC Cancer
MCV–Neutropenia Risk Score and Overall Survival in HR+/HER2− Advanced Breast Cancer: A Multicenter Retrospective Landmark Analysis
2026
·
Fatih Atalah
, Aydın Acarbay
, et al.
·
Breast Cancer Targets and Therapy
PDF
Real-World Efficacy and Safety of Frontline Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma: A Multicenter Study and Review of the Literature
2026
·
Cevat İlteriş Kıkılı
, Murat Araz
, et al.
·
Clinical Genitourinary Cancer
Does Surgical Timing After Neoadjuvant Anti‐HER2 Therapy Affect Pathological Complete Response and Survival in HER2‐Positive Breast Cancer? A Multicenter Retrospective Cohort Study
2026
·
Zeliha Birsin
, Onur Alkan
, et al.
·
Journal of Surgical Oncology
PDF
Comment on “PARP-1 rs1136410 Polymorphism and Gastrointestinal Cancer Risk: A Meta-Analysis of Cancer-Type and Ethnic-Specific Associations”
2026
·
Onur ALKAN
, Ismail NAZLI
, et al.
·
Medeniyet Medical Journal
PDF
Cross-Model and Cross-Version Evaluation of Large Language Models in Breast Cancer Tumor Board Decision Support
2026
·
ONUR ALKAN
, Fatih Atalah
, et al.
·
SSRN Electronic Journal
PDF
KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPI
2025
·
Fatih Atalah
, Fatih Kuş
, et al.
·
Journal of Clinical Medicine
PDF
Cytokine and Chemokine Profiles in COVID-19: Why Did Conventional Inflammatory Markers Outperform Cytokines?
2025
·
Onur Alkan
, Naci Şenkal
, et al.
·
Eurasian Journal of Medical Advances
PDF
Combined Treatments for Metastatic Prostate Cancer
2024
·
Sinan Koca
, Onur Alkan
High levels of circulating IL-6 and IL-8 signature predicts COVID-19 severity
2024
·
Didem OZGUR
, MURAT KARAMESE
, et al.
PDF
Op0313 Preliminary Criteria for Macrophage Activation Syndrome Associated With Coronavirus Disease-19
2021
·
S. Amikishiyev
, M.G. Gunver
, et al.
·
Annals of the Rheumatic Diseases
PDF
Show more works
View as search
Works count:
23
Citation count:
29
H-index:
3
I10-index:
1
Year
Topic
Type